Boston Scientific Corp (BSX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) for Boston Scientific Corp are not provided in the data available. DSO is a metric that measures how long it takes for a company to collect outstanding receivables from its customers. It is calculated by dividing accounts receivable by average daily sales.
Without specific DSO figures, we are unable to analyze Boston Scientific Corp's efficiency in collecting payments from customers and managing its accounts receivable effectively. Monitoring DSO trends over time can provide insights into the company's liquidity, credit policies, and overall financial health.
To perform a thorough analysis of Boston Scientific Corp's DSO, we would need access to the actual DSO figures for each reporting period to assess any changes, compare the company's performance against industry benchmarks, and evaluate the impact on cash flow and working capital management.
Peer comparison
Dec 31, 2024
See also:
Boston Scientific Corp Average Receivable Collection Period (Quarterly Data)